Man Group’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $352K | Buy |
+20,171
| New | +$400K | ﹤0.01% | 2177 |
|
|
2025
Q4 | – | Sell |
-22,586
| Closed | -$622K | – | 2485 |
|
|
2025
Q3 | $622K | Sell |
22,586
-956
| -4% | -$29.4K | ﹤0.01% | 1802 |
|
|
2025
Q2 | $719K | Sell |
23,542
-45,286
| -66% | -$1.29M | ﹤0.01% | 1716 |
|
|
2025
Q1 | $1.86M | Buy |
68,828
+47,836
| +228% | +$1.51M | ﹤0.01% | 1387 |
|
|
2024
Q4 | $753K | Hold |
20,992
| – | – | ﹤0.01% | 1561 |
|
|
2024
Q3 | $796K | Sell |
20,992
-2,805
| -12% | -$115K | ﹤0.01% | 1551 |
|
|
2024
Q2 | $1.08M | Sell |
23,797
-3,884
| -14% | -$179K | ﹤0.01% | 1505 |
|
|
2024
Q1 | $1.34M | Buy |
27,681
+1,584
| +6% | +$77.6K | ﹤0.01% | 1450 |
|
|
2023
Q4 | $1.4M | Buy |
+26,097
| New | +$1.32M | ﹤0.01% | 1363 |
|
|
2023
Q3 | – | Sell |
-42,746
| Closed | -$2.67M | – | 1105 |
|
|
2023
Q2 | $2.69M | Buy |
+42,746
| New | +$2.72M | 0.01% | 1098 |
|
|
2023
Q1 | – | Sell |
-28,338
| Closed | -$1.69M | – | 1142 |
|
|
2022
Q4 | $1.51M | Buy |
28,338
+17
| +0.1% | +$921 | 0.01% | 1200 |
|
|
2022
Q3 | $1.59M | Buy |
+28,321
| New | +$1.87M | 0.01% | 1150 |
|
|
2022
Q2 | – | Sell |
-38,476
| Closed | -$2.87M | – | 1086 |
|
|
2022
Q1 | $3.06M | Buy |
38,476
+664
| +2% | +$59.9K | 0.01% | 1085 |
|
|
2021
Q4 | $3.83M | Sell |
37,812
-78,857
| -68% | -$7.87M | 0.01% | 976 |
|
|
2021
Q3 | $10.8M | Sell |
116,669
-14,617
| -11% | -$1.41M | 0.04% | 540 |
|
|
2021
Q2 | $13.4M | Sell |
131,286
-84,441
| -39% | -$8.48M | 0.05% | 454 |
|
|
2021
Q1 | $21.1M | Sell |
215,727
-99
| -0% | -$9.01K | 0.09% | 229 |
|
|
2020
Q4 | $16.6M | Buy |
215,826
+20,433
| +10% | +$1.58M | 0.07% | 267 |
|
|
2020
Q3 | $14.4M | Buy |
195,393
+52,091
| +36% | +$4.18M | 0.06% | 358 |
|
|
2020
Q2 | $10.5M | Sell |
143,302
-3,126
| -2% | -$245K | 0.05% | 344 |
|
|
2020
Q1 | $8.46M | Sell |
146,428
-29,472
| -17% | -$2.05M | 0.05% | 342 |
|
|
2019
Q4 | $13.8M | Buy |
175,900
+19,500
| +12% | +$1.44M | 0.05% | 516 |
|
|
2019
Q3 | $10.7M | Sell |
156,400
-54,319
| -26% | -$3.65M | 0.04% | 556 |
|
|
2019
Q2 | $16.7M | Sell |
210,719
-9,359
| -4% | -$742K | 0.06% | 400 |
|
|
2019
Q1 | $18.5M | Buy |
220,078
+143,083
| +186% | +$14.9M | 0.07% | 340 |
|
|
2018
Q4 | $9.06M | Sell |
76,995
-91,950
| -54% | -$10.6M | 0.04% | 494 |
|
|
2018
Q3 | $20.4M | Buy |
168,945
+42,850
| +34% | +$5.32M | 0.07% | 317 |
|
|
2018
Q2 | $14.5M | Sell |
126,095
-7,005
| -5% | -$766K | 0.06% | 396 |
|
|
2018
Q1 | $11.4M | Buy |
+133,100
| New | +$10.3M | 0.05% | 423 |
|
Other funds holding USNA
NCM
VCM
VPM
Man Group's USNA Position: Q1 2026 in Review
Man Group opened a new position in Usana Health Sciences (USNA) in Q1 2026: 20,171 shares worth $352K. The stake represents ﹤0.01% of the portfolio and ranks #2177 among its holdings. This is a return to the name: Man Group previously reported a position in USNA as recently as Q3 2025.
Man Group first reported a position in USNA in Q1 2018 and has held it in 29 quarters since. The position peaked at $21.1M in Q1 2021. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.
- Man Group held 20,171 shares of Usana Health Sciences worth $352K as of Q1 2026.
- Usana Health Sciences was a new Man Group position in Q1 2026.
- Usana Health Sciences made up ﹤0.01% of Man Group's portfolio in Q1 2026, its #2177 holding.
- Man Group first reported a position in Usana Health Sciences in Q1 2018 and has held it in 29 quarters since.
- Man Group's Usana Health Sciences position peaked at $21.1M in Q1 2021.
- 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.
Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.